報價延遲最少15分鐘:2026/05/29 14:26 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.41 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.83/--
|
|
企業價值
31.18M
|
| 資產負債 |
|
每股賬面淨值
0.77
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
124.16K
|
|
每股收益
0.02
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format. |
